A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells

Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments. Herein, based on the cell-penetrating motif of an antican...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2013-06, Vol.8 (6), p.e66084-e66084
Hauptverfasser: Lim, Ki Jung, Sung, Bong Hyun, Shin, Ju Ri, Lee, Young Woong, Kim, Da Jung, Yang, Kyung Seok, Kim, Sun Chang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e66084
container_issue 6
container_start_page e66084
container_title PloS one
container_volume 8
creator Lim, Ki Jung
Sung, Bong Hyun
Shin, Ju Ri
Lee, Young Woong
Kim, Da Jung
Yang, Kyung Seok
Kim, Sun Chang
description Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments. Herein, based on the cell-penetrating motif of an anticancer peptide, buforin IIb, we designed several CPP derivatives with cancer cell specificity. Among the derivatives, a 17-amino acid peptide (BR2) was found to have cancer-specificity without toxicity to normal cells. After specifically targeting cancer cells through interaction with gangliosides, BR2 entered cells via lipid-mediated macropinocytosis. Moreover, BR2 showed higher membrane translocation efficiency than the well-known CPP Tat (49-57). The capability of BR2 as a cancer-specific drug carrier was demonstrated by fusion of BR2 to a single-chain variable fragment (scFv) directed toward a mutated K-ras (G12V). BR2-fused scFv induced a higher degree of apoptosis than Tat-fused scFv in K-ras mutated HCT116 cells. These results suggest that the novel cell-penetrating peptide BR2 has great potential as a useful drug delivery carrier with cancer cell specificity.
doi_str_mv 10.1371/journal.pone.0066084
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1366648213</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478325780</galeid><doaj_id>oai_doaj_org_article_af33a5d768a341c1aacfa0c6fe654f70</doaj_id><sourcerecordid>A478325780</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-1fbeeb7136965665c06760df770507183da31ab030be64dce04068f79d5f74723</originalsourceid><addsrcrecordid>eNqNk19r2zAUxc3YWLtu32BsgsHYoMkky5bsl0FW1i1QKHR_XoUiXyUKjuRKcli__eTGKcnow_CDjPQ7R_ce-2bZa4KnhHLyae16b2U77ZyFKcaM4ap4kp2SmuYTlmP69OD9JHsRwhrjklaMPc9Ocsp5EtSn2WqGlLQKPAodKKONQgradtKBhehlNHaJOuiiaeAcfbnJz5F2HsUVINAJNmAjaqA1W_B3yGkkLQrqcouMjW7vPBiGl9kzLdsAr8b1LPt1-fXnxffJ1fW3-cXsaqJYnccJ0QuABSeU1axkrFSYcYYbzTkuMScVbSQlcoEpXgArGgW4wKzSvG5KzQue07Ps7c63a10QY0hBJEPGiionNBHzHdE4uRadNxvp74STRtxvOL8U0kejWhBSUyrLhrNK0oIoIqXSEiumgZWF5jh5fR5v6xcbSOXYFFp7ZHp8Ys1KLN1WUMZrnA_lfhgNvLvtIUSxMWEITFpw_X3d9dA2rRP67h_08e5GailTA8Zql-5Vg6mYFbyiecmroe7pI1R6GtgYlf4obdL-keDjkSAxEf7EpexDEPMfN__PXv8-Zt8fsCuQbVwF1_bROBuOwWIHKu9C8KAfQiZYDAOxT0MMAyHGgUiyN4cf6EG0nwD6F4PvBFU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1366648213</pqid></control><display><type>article</type><title>A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Lim, Ki Jung ; Sung, Bong Hyun ; Shin, Ju Ri ; Lee, Young Woong ; Kim, Da Jung ; Yang, Kyung Seok ; Kim, Sun Chang</creator><contributor>Sobol, Robert W.</contributor><creatorcontrib>Lim, Ki Jung ; Sung, Bong Hyun ; Shin, Ju Ri ; Lee, Young Woong ; Kim, Da Jung ; Yang, Kyung Seok ; Kim, Sun Chang ; Sobol, Robert W.</creatorcontrib><description>Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments. Herein, based on the cell-penetrating motif of an anticancer peptide, buforin IIb, we designed several CPP derivatives with cancer cell specificity. Among the derivatives, a 17-amino acid peptide (BR2) was found to have cancer-specificity without toxicity to normal cells. After specifically targeting cancer cells through interaction with gangliosides, BR2 entered cells via lipid-mediated macropinocytosis. Moreover, BR2 showed higher membrane translocation efficiency than the well-known CPP Tat (49-57). The capability of BR2 as a cancer-specific drug carrier was demonstrated by fusion of BR2 to a single-chain variable fragment (scFv) directed toward a mutated K-ras (G12V). BR2-fused scFv induced a higher degree of apoptosis than Tat-fused scFv in K-ras mutated HCT116 cells. These results suggest that the novel cell-penetrating peptide BR2 has great potential as a useful drug delivery carrier with cancer cell specificity.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0066084</identifier><identifier>PMID: 23776609</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Amino acids ; Apoptosis ; Apoptosis - physiology ; Biology ; Blotting, Western ; Cancer ; Cancer cells ; Cancer therapies ; Cancer treatment ; Cell Proliferation ; Cell-Penetrating Peptides - chemistry ; Cell-Penetrating Peptides - metabolism ; Cytotoxicity ; Derivatives ; Design ; Drug carriers ; Drug delivery ; Drug delivery systems ; Endocytosis - physiology ; Fibroblasts ; Gangliosides ; HCT116 Cells ; HeLa Cells ; Hemolysis - physiology ; Humans ; K-Ras protein ; Medicine ; Metastasis ; Microscopy ; Microscopy, Confocal ; Peptides ; Proteins ; Quantum dots ; Science ; Single-Chain Antibodies - chemistry ; Single-Chain Antibodies - metabolism ; Toxicity ; Translocation</subject><ispartof>PloS one, 2013-06, Vol.8 (6), p.e66084-e66084</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 Lim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 Lim et al 2013 Lim et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-1fbeeb7136965665c06760df770507183da31ab030be64dce04068f79d5f74723</citedby><cites>FETCH-LOGICAL-c692t-1fbeeb7136965665c06760df770507183da31ab030be64dce04068f79d5f74723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679022/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679022/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23776609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Sobol, Robert W.</contributor><creatorcontrib>Lim, Ki Jung</creatorcontrib><creatorcontrib>Sung, Bong Hyun</creatorcontrib><creatorcontrib>Shin, Ju Ri</creatorcontrib><creatorcontrib>Lee, Young Woong</creatorcontrib><creatorcontrib>Kim, Da Jung</creatorcontrib><creatorcontrib>Yang, Kyung Seok</creatorcontrib><creatorcontrib>Kim, Sun Chang</creatorcontrib><title>A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments. Herein, based on the cell-penetrating motif of an anticancer peptide, buforin IIb, we designed several CPP derivatives with cancer cell specificity. Among the derivatives, a 17-amino acid peptide (BR2) was found to have cancer-specificity without toxicity to normal cells. After specifically targeting cancer cells through interaction with gangliosides, BR2 entered cells via lipid-mediated macropinocytosis. Moreover, BR2 showed higher membrane translocation efficiency than the well-known CPP Tat (49-57). The capability of BR2 as a cancer-specific drug carrier was demonstrated by fusion of BR2 to a single-chain variable fragment (scFv) directed toward a mutated K-ras (G12V). BR2-fused scFv induced a higher degree of apoptosis than Tat-fused scFv in K-ras mutated HCT116 cells. These results suggest that the novel cell-penetrating peptide BR2 has great potential as a useful drug delivery carrier with cancer cell specificity.</description><subject>Amino acids</subject><subject>Apoptosis</subject><subject>Apoptosis - physiology</subject><subject>Biology</subject><subject>Blotting, Western</subject><subject>Cancer</subject><subject>Cancer cells</subject><subject>Cancer therapies</subject><subject>Cancer treatment</subject><subject>Cell Proliferation</subject><subject>Cell-Penetrating Peptides - chemistry</subject><subject>Cell-Penetrating Peptides - metabolism</subject><subject>Cytotoxicity</subject><subject>Derivatives</subject><subject>Design</subject><subject>Drug carriers</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>Endocytosis - physiology</subject><subject>Fibroblasts</subject><subject>Gangliosides</subject><subject>HCT116 Cells</subject><subject>HeLa Cells</subject><subject>Hemolysis - physiology</subject><subject>Humans</subject><subject>K-Ras protein</subject><subject>Medicine</subject><subject>Metastasis</subject><subject>Microscopy</subject><subject>Microscopy, Confocal</subject><subject>Peptides</subject><subject>Proteins</subject><subject>Quantum dots</subject><subject>Science</subject><subject>Single-Chain Antibodies - chemistry</subject><subject>Single-Chain Antibodies - metabolism</subject><subject>Toxicity</subject><subject>Translocation</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk19r2zAUxc3YWLtu32BsgsHYoMkky5bsl0FW1i1QKHR_XoUiXyUKjuRKcli__eTGKcnow_CDjPQ7R_ce-2bZa4KnhHLyae16b2U77ZyFKcaM4ap4kp2SmuYTlmP69OD9JHsRwhrjklaMPc9Ocsp5EtSn2WqGlLQKPAodKKONQgradtKBhehlNHaJOuiiaeAcfbnJz5F2HsUVINAJNmAjaqA1W_B3yGkkLQrqcouMjW7vPBiGl9kzLdsAr8b1LPt1-fXnxffJ1fW3-cXsaqJYnccJ0QuABSeU1axkrFSYcYYbzTkuMScVbSQlcoEpXgArGgW4wKzSvG5KzQue07Ps7c63a10QY0hBJEPGiionNBHzHdE4uRadNxvp74STRtxvOL8U0kejWhBSUyrLhrNK0oIoIqXSEiumgZWF5jh5fR5v6xcbSOXYFFp7ZHp8Ys1KLN1WUMZrnA_lfhgNvLvtIUSxMWEITFpw_X3d9dA2rRP67h_08e5GailTA8Zql-5Vg6mYFbyiecmroe7pI1R6GtgYlf4obdL-keDjkSAxEf7EpexDEPMfN__PXv8-Zt8fsCuQbVwF1_bROBuOwWIHKu9C8KAfQiZYDAOxT0MMAyHGgUiyN4cf6EG0nwD6F4PvBFU</recordid><startdate>20130611</startdate><enddate>20130611</enddate><creator>Lim, Ki Jung</creator><creator>Sung, Bong Hyun</creator><creator>Shin, Ju Ri</creator><creator>Lee, Young Woong</creator><creator>Kim, Da Jung</creator><creator>Yang, Kyung Seok</creator><creator>Kim, Sun Chang</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20130611</creationdate><title>A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells</title><author>Lim, Ki Jung ; Sung, Bong Hyun ; Shin, Ju Ri ; Lee, Young Woong ; Kim, Da Jung ; Yang, Kyung Seok ; Kim, Sun Chang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-1fbeeb7136965665c06760df770507183da31ab030be64dce04068f79d5f74723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Amino acids</topic><topic>Apoptosis</topic><topic>Apoptosis - physiology</topic><topic>Biology</topic><topic>Blotting, Western</topic><topic>Cancer</topic><topic>Cancer cells</topic><topic>Cancer therapies</topic><topic>Cancer treatment</topic><topic>Cell Proliferation</topic><topic>Cell-Penetrating Peptides - chemistry</topic><topic>Cell-Penetrating Peptides - metabolism</topic><topic>Cytotoxicity</topic><topic>Derivatives</topic><topic>Design</topic><topic>Drug carriers</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>Endocytosis - physiology</topic><topic>Fibroblasts</topic><topic>Gangliosides</topic><topic>HCT116 Cells</topic><topic>HeLa Cells</topic><topic>Hemolysis - physiology</topic><topic>Humans</topic><topic>K-Ras protein</topic><topic>Medicine</topic><topic>Metastasis</topic><topic>Microscopy</topic><topic>Microscopy, Confocal</topic><topic>Peptides</topic><topic>Proteins</topic><topic>Quantum dots</topic><topic>Science</topic><topic>Single-Chain Antibodies - chemistry</topic><topic>Single-Chain Antibodies - metabolism</topic><topic>Toxicity</topic><topic>Translocation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lim, Ki Jung</creatorcontrib><creatorcontrib>Sung, Bong Hyun</creatorcontrib><creatorcontrib>Shin, Ju Ri</creatorcontrib><creatorcontrib>Lee, Young Woong</creatorcontrib><creatorcontrib>Kim, Da Jung</creatorcontrib><creatorcontrib>Yang, Kyung Seok</creatorcontrib><creatorcontrib>Kim, Sun Chang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lim, Ki Jung</au><au>Sung, Bong Hyun</au><au>Shin, Ju Ri</au><au>Lee, Young Woong</au><au>Kim, Da Jung</au><au>Yang, Kyung Seok</au><au>Kim, Sun Chang</au><au>Sobol, Robert W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-06-11</date><risdate>2013</risdate><volume>8</volume><issue>6</issue><spage>e66084</spage><epage>e66084</epage><pages>e66084-e66084</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments. Herein, based on the cell-penetrating motif of an anticancer peptide, buforin IIb, we designed several CPP derivatives with cancer cell specificity. Among the derivatives, a 17-amino acid peptide (BR2) was found to have cancer-specificity without toxicity to normal cells. After specifically targeting cancer cells through interaction with gangliosides, BR2 entered cells via lipid-mediated macropinocytosis. Moreover, BR2 showed higher membrane translocation efficiency than the well-known CPP Tat (49-57). The capability of BR2 as a cancer-specific drug carrier was demonstrated by fusion of BR2 to a single-chain variable fragment (scFv) directed toward a mutated K-ras (G12V). BR2-fused scFv induced a higher degree of apoptosis than Tat-fused scFv in K-ras mutated HCT116 cells. These results suggest that the novel cell-penetrating peptide BR2 has great potential as a useful drug delivery carrier with cancer cell specificity.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23776609</pmid><doi>10.1371/journal.pone.0066084</doi><tpages>e66084</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2013-06, Vol.8 (6), p.e66084-e66084
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1366648213
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Amino acids
Apoptosis
Apoptosis - physiology
Biology
Blotting, Western
Cancer
Cancer cells
Cancer therapies
Cancer treatment
Cell Proliferation
Cell-Penetrating Peptides - chemistry
Cell-Penetrating Peptides - metabolism
Cytotoxicity
Derivatives
Design
Drug carriers
Drug delivery
Drug delivery systems
Endocytosis - physiology
Fibroblasts
Gangliosides
HCT116 Cells
HeLa Cells
Hemolysis - physiology
Humans
K-Ras protein
Medicine
Metastasis
Microscopy
Microscopy, Confocal
Peptides
Proteins
Quantum dots
Science
Single-Chain Antibodies - chemistry
Single-Chain Antibodies - metabolism
Toxicity
Translocation
title A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A12%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20cancer%20specific%20cell-penetrating%20peptide,%20BR2,%20for%20the%20efficient%20delivery%20of%20an%20scFv%20into%20cancer%20cells&rft.jtitle=PloS%20one&rft.au=Lim,%20Ki%20Jung&rft.date=2013-06-11&rft.volume=8&rft.issue=6&rft.spage=e66084&rft.epage=e66084&rft.pages=e66084-e66084&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0066084&rft_dat=%3Cgale_plos_%3EA478325780%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1366648213&rft_id=info:pmid/23776609&rft_galeid=A478325780&rft_doaj_id=oai_doaj_org_article_af33a5d768a341c1aacfa0c6fe654f70&rfr_iscdi=true